• OPEN AN ACCOUNT
Indian Indices
Nifty
22,272.50 -246.90
(-1.10%)
Sensex
72,724.45 -675.33
( -0.92%)
Bank Nifty
47,773.25 -791.30
( -1.63%)
Nifty IT
34,463.60 -554.50
( -1.58%)
Global Indices
Nasdaq
15,885.02 -290.07
(-1.79%)
Dow Jones
37,735.11 -248.13
(-0.65%)
Hang Seng
16,600.46 -121.23
(-0.73%)
Nikkei 225
38,471.20 -761.60
(-1.94%)
Forex
USD-INR
83.61 0.25
(0.30%)
EUR-INR
88.96 -0.50
(-0.56%)
GBP-INR
104.08 -0.51
(-0.49%)
JPY-INR
0.55 0.00
(0.15%)

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
506197
INE416D01022
93.382807
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BLISSGVS
16.89
1153.17
EPS(TTM)
Face Value()
Div & Yield %
6.52
1
0.45
 

ntpc ltd
NTPC Ltd - NTPC Limited - Updates
Jun 06,2023
NTPC Limited has informed the Exchange regarding Declaration of COD of second part capacity of 10 MW of 20 MW Gandhar Solar PV Project. Consequent upon successful commissioning, second part capacity of 10 MW of 20 MW Gandhar Solar PV Project at Gandhar, Gujarat, is declared on Commercial Operation w.e.f. 00:00 Hrs. of 07.06.2023. The first part capacity of 10 MW has already been declared on commercial operation w.e.f. 00:00 Hrs. of 23.08.2022. With this, standalone installed and commercial capacity of NTPC will become 56378 MW, while group installed and commercial capacity of NTPC will become 72364 MW.